You're contacting media contact of this press release

Title: RightWell Unveils Revitol Ozempic Face Cream, a Clinically Proven Peptide and Collagen Formula for GLP-1 Skin Aging

MIAMI, FL — RightWell, a leader in science-backed GLP-1 Treatments, wellness and nutraceutical solutions, today announced the launch of Revitol Ozempic Face Defense Cream, an advanced topical skincare system engineered to address the most visible and distressing cosmetic side effects of GLP-1 medications such as Ozempic®, Wegovy®, Mounjaro®, and Zepbound® — commonly known as “Ozempic Face.”Learn More: RightWell's Revitol GLP-1 Ozempic Face Defense CreamWhat Is “Ozempic Face” and Why Does It Happen?As millions of Americans turn to GLP-1 receptor agonists for weight loss, a growing number are experiencing an unintended consequence: rapid facial volume loss resulting in hollowed cheeks, sagging jawlines, deepened wrinkles, and a prematurely aged appearance. This phenomenon — colloquially dubbed “Ozempic Face” — occurs because GLP-1 medications accelerate fat metabolism faster than skin can adapt, collapsing the structural fat pads beneath the face that give skin its youthful fullness and firmness.Until now, the primary clinical solution has been costly dermal filler injections. Revitol Ozempic Face Cream offers an accessible, non-invasive alternative designed to work proactively and continuously alongside a GLP-1 regimen.Introducing the Ultimate GLP-1 Face Defense System by RightWellRevitol Ozempic Face Cream is the cornerstone of RightWell’s Ultimate GLP-1 Face Defense System, available exclusively at shop.rightwell.com. The system is formulated to target the four primary skin concerns associated with GLP-1 weight loss medications:•  Deflation — restoring lost facial volume, especially in the cheeks, temples, and jawline•  Deep Wrinkles — smoothing and preventing fine lines accelerated by rapid weight loss•  Dehydration — deeply replenishing moisture and re...

This press release is issued by King Newswire